Search - tctmd.com

Displaying 101 - 120 of 397

Sort: Relevancy | Date

Presentation TCT 2018

Keynote Lecture: FDA/CDRH - The Year in Review

Presenter: Mitchell W. Krucoff, Gregg W. Stone, William H. Maisel

September 22, 2018

Presentation TCT 2018

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

Presenter: Mitchell W. Krucoff, Gregg W. Stone, Martin B. Leon

September 22, 2018

Presentation TCT 2018

Is It Time to Move Beyond Angiography for Procedural Planning? DECISION

Presenter: Antonio Colombo, Jeffrey W. Moses, Gregg W. Stone

September 22, 2018

Presentation TCT 2018

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

Presenter: Gregg W. Stone, Pieter R. Stella

September 22, 2018

Presentation TCT 2018

BIONYX: A Randomized Trial Evaluating a Thin Composite Wire Strut Durable Polymer-Based DES Compared with an Ultra-Thin Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

Presenter: Gregg W. Stone, Clemens von Birgelen

September 22, 2018

Presentation TCT 2018

TCT 2018 Geoffrey O. Hartzler Master Operator Award

Presenter: Martin B. Leon, Gregg W. Stone

September 22, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

L.A. McKeown

November 02, 2017

Presentation TCT 2017

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, William F. Fearon

November 02, 2017

Presentation TCT 2017

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

Presenter: Gregg W. Stone, Rasha Al-Lamee

November 02, 2017

Presentation TCT 2017

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Gregg W. Stone

November 01, 2017

Presentation TCT 2017

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Presenter: Gregg W. Stone, Peter H. Stone, Jung-Min Ahn

November 01, 2017

Presentation TCT 2017

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

Presenter: Gregg W. Stone, Peter H. Stone, Evan A. Stein

November 01, 2017

Presentation TCT 2017

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

Presenter: Robert A. Harrington, Gregg W. Stone, Harry Suryapranata

November 01, 2017

Presentation TCT 2017

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

Presenter: Robert A. Harrington, Gregg W. Stone, Elvin Kedhi

November 01, 2017

Presentation TCT 2017

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne

November 01, 2017

Presentation TCT 2017

Supersaturated Oxygen for Large Anterior STEMI: Results of the IC-HOT Approval Study

Presenter: Bernard J. Gersh, Michel Ovize, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

Inter-atrial Shunts I: V-Wave

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Gregg W. Stone

October 31, 2017

Presentation TCT 2017

The Role of Left Main PCI After EXCEL and NOBLE

Presenter: Alaide Chieffo, Jonathan M. Hill, Gregg W. Stone

October 31, 2017

Advertisement

Keynote Lecture: FDA/CDRH - The Year in Review

The TCT FDA Town Hall Meetings in Perspective: A Multidisciplinary Collaborative Venture

Is It Time to Move Beyond Angiography for Procedural Planning? DECISION

ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population

BIONYX: A Randomized Trial Evaluating a Thin Composite Wire Strut Durable Polymer-Based DES Compared with an Ultra-Thin Strut Bioresorbable Polymer-Based DES in an All-Comers Patient Population

TCT 2018 Geoffrey O. Hartzler Master Operator Award

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

FAME 2: 3-Year Clinical and Cost-effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

ORBITA: A Randomized, Sham-Controlled Trial of PCI in Patients With Coronary Artery Disease

ABSORB II 4-Year, ABSORB III 3-Year, ABSORB IV 30-Day: Highlights Summary

Bioresorbable Scaffolds and Stents: From PROSPECT-ABSORB to PREVENT (With Case Examples)

Keynote Lecture: Personalized Treatment of the Vulnerable Patient With PCSK9 Inhibitors, Anti-inflammatory Therapies and CTEP Inhibitors

REDUCE: A Randomized Trial of 3-Month vs 12-Month DAPT After Implantation of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating in Patients With ACS

DAPT STEMI: A Randomized Trial of 6-Month vs 12-Month DAPT After DES Implantation in STEMI

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Supersaturated Oxygen for Large Anterior STEMI: Results of the IC-HOT Approval Study

Inter-atrial Shunts I: V-Wave

The Role of Left Main PCI After EXCEL and NOBLE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content